Baidu
map

年轻乳腺癌ofs+AI后仍未绝经,后续如何进行内分泌治疗?

2021-07-07 MedSci原创 MedSci原创

年轻乳腺癌ofs+AI后仍未绝经,后续如何内分泌治疗?

《梅斯直播课:3天乳腺癌诊疗训练营》
06.25-年轻乳腺癌的治疗要点及生育管理
回答问题7:年轻乳腺癌ofs+AI后仍未绝经,后续如何内分泌治疗?

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1968624, encodeId=516a19686243f, content=<a href='/topic/show?id=e18a132e014' target=_blank style='color:#2F92EE;'>#OFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13270, encryptionId=e18a132e014, topicName=OFS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sat Jul 31 12:39:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769266, encodeId=4be51e692661a, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Mon Mar 14 07:39:24 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682678, encodeId=319e16826e841, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Aug 10 11:39:24 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257273, encodeId=04f7125e27365, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Jul 09 08:39:24 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997317, encodeId=5b7799e31796, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:23:35 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-31 appleandpeer
  2. [GetPortalCommentsPageByObjectIdResponse(id=1968624, encodeId=516a19686243f, content=<a href='/topic/show?id=e18a132e014' target=_blank style='color:#2F92EE;'>#OFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13270, encryptionId=e18a132e014, topicName=OFS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sat Jul 31 12:39:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769266, encodeId=4be51e692661a, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Mon Mar 14 07:39:24 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682678, encodeId=319e16826e841, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Aug 10 11:39:24 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257273, encodeId=04f7125e27365, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Jul 09 08:39:24 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997317, encodeId=5b7799e31796, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:23:35 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1968624, encodeId=516a19686243f, content=<a href='/topic/show?id=e18a132e014' target=_blank style='color:#2F92EE;'>#OFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13270, encryptionId=e18a132e014, topicName=OFS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sat Jul 31 12:39:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769266, encodeId=4be51e692661a, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Mon Mar 14 07:39:24 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682678, encodeId=319e16826e841, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Aug 10 11:39:24 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257273, encodeId=04f7125e27365, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Jul 09 08:39:24 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997317, encodeId=5b7799e31796, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:23:35 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1968624, encodeId=516a19686243f, content=<a href='/topic/show?id=e18a132e014' target=_blank style='color:#2F92EE;'>#OFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13270, encryptionId=e18a132e014, topicName=OFS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sat Jul 31 12:39:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769266, encodeId=4be51e692661a, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Mon Mar 14 07:39:24 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682678, encodeId=319e16826e841, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Aug 10 11:39:24 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257273, encodeId=04f7125e27365, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Jul 09 08:39:24 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997317, encodeId=5b7799e31796, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:23:35 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1968624, encodeId=516a19686243f, content=<a href='/topic/show?id=e18a132e014' target=_blank style='color:#2F92EE;'>#OFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13270, encryptionId=e18a132e014, topicName=OFS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sat Jul 31 12:39:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769266, encodeId=4be51e692661a, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Mon Mar 14 07:39:24 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682678, encodeId=319e16826e841, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Aug 10 11:39:24 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257273, encodeId=04f7125e27365, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Fri Jul 09 08:39:24 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997317, encodeId=5b7799e31796, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:23:35 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 机智哈

    学习一下

    0

相关资讯

年轻乳腺癌的肿瘤特征是什么?复发风险和预后有何特点?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

BRCA1/2突变的年轻患者是否适宜保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

阳性且有转移的乳腺癌患者是只能注射靶向药治疗吗?

《梅斯直播课:3天乳腺癌诊疗训练营》 06.25-年轻乳腺癌的治疗要点及生育管理 回答问题6:阳性且有转移的治疗是只能一直打靶向药么?

乳腺粘液性癌术后治疗

《梅斯直播课:3天乳腺癌诊疗训练营》问题回答11:乳腺粘液性癌病例分析

年轻乳腺癌应选择乳房切除术还是保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

拓展阅读

Nature Genetics:揭示女性生育力的基因密码:CCDC201变异对绝经和生育的深远影响

这项发现不仅为POI的遗传机制提供了新的见解,也凸显了在基因筛查中考虑不同遗传模型的重要性。

AMH能诊断和预测绝经/卵巢功能不全吗?

本系统评价旨在确定是否有证据支持单独使用AMH或与其他标志物联合用于诊断绝经,预测绝经,或预测和/或诊断卵巢功能不全(POI)。

JAMA Netw Open:女性生殖因素和子宫内膜癌风险

这项对个体参与者数据进行的大型汇总研究发现,初潮较晚、绝经较早和分娩次数较多与子宫内膜癌风险较低显著相关。

JAMA Netw Open:经前疾病、绝经时间和血管舒缩症状的严重程度

PMD 与提前绝经和中度或重度 VMS 的风险增加有关。PMD 可能提示与早期绝经和 VMS 相关的潜在生理学,表明在育龄期可观察到的这一表型,可能让临床医生针对有更年期提前风险和随后生命历程后期健康

AJOG:不孕、流产、死产和过早和提前绝经之间有联系吗?9项队列研究的汇总分析结果

本研究表明,不孕史以及复发性流产和死产与过早绝经和提前绝经的风险较高有关,并且这些关联因种族而异,具有此类生殖史的亚洲女性的关联性更强。

Hypertension:绝经妇女雌激素治疗给药途径和配方与高血压风险之间的关系

口服雌激素治疗与女性高血压风险增加有关。在使用雌激素激素治疗的妇女中,最低剂量和最短时间非口服雌二醇与最低的高血压风险相关。

Baidu
map
Baidu
map
Baidu
map